Evidence map›Paper›PMID 33379181›Full record

Trial reportNutrients2020

Effect of an Enriched Protein Drink on Muscle Mass and Glycemic Control during Combined Lifestyle Intervention in Older Adults with Obesity and Type 2 Diabetes: A Double-Blind RCT.

Robert G Memelink, Wilrike J Pasman, Anke Bongers, Anita Tump, Annemieke van Ginkel, Wim Tromp, Suzan Wopereis, Sjors Verlaan, Johan de Vogel-van den Bosch, Peter J M Weijs

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Article
  15. Article
  16. Review
  17. Optimizing Nutrition Strategies for Diabetes Management in India: An Expert Opinion.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Robert G MemelinkDepartment of Nutrition and Dietetics, Faculty of Sports and Nutrition, Center of Expertise Urban Vitality, Amsterdam University of Applied Sciences, 1067 SM Amsterdam, The Netherlands.ORCID 0000-0003-0780-7360
Wilrike J PasmanNetherlands Organisation for Applied Scientific Research (TNO), 3704 HE Zeist, The Netherlands.ORCID 0000-0001-6962-2674
Anke BongersDanone Nutricia Research, Specialized Nutrition, 3584 CT Utrecht, The Netherlands.
Anita TumpVialente-Diëtheek, 3447 GW Woerden, The Netherlands.
Annemieke van GinkelVialente-Diëtheek, 3447 GW Woerden, The Netherlands.
Wim TrompTromp Medical, 1901 ND Castricum, The Netherlands.
Suzan WopereisNetherlands Organisation for Applied Scientific Research (TNO), 3704 HE Zeist, The Netherlands.ORCID 0000-0001-9612-657X
Sjors VerlaanDepartment of Rehabilitation Medicine, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-0377-7398
Johan de Vogel-van den BoschDanone Nutricia Research, Specialized Nutrition, 3584 CT Utrecht, The Netherlands.ORCID 0000-0001-5249-3992
Peter J M WeijsDepartment of Nutrition and Dietetics, Faculty of Sports and Nutrition, Center of Expertise Urban Vitality, Amsterdam University of Applied Sciences, 1067 SM Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLDanone (Netherlands) · NLNetherlands Organisation for Applied Scientific Research · NLAmsterdam University of Applied Sciences · NLTromp Medical (Netherlands) · NL

Funding

Danone Nutricia Research study products, financial support for conducting the studyDutch Research Council (NWO) 023.009.065Topsector Agri & Food, The Netherlands AF12174
6 · The paper itself

Abstract

backgroundWeight loss is key to treatment of older adults with obesity and type 2 diabetes, but also a risk for muscle mass loss. This study investigated whether a whey protein drink enriched with leucine and vitamin D could preserve muscle mass and improve glycemic control during combined lifestyle intervention in this population.

methods123 older adults with obesity and type 2 diabetes were randomized into a 13-week lifestyle intervention with dietary advice and exercise, receiving either the enriched protein drink (test) or an isocaloric control (control). Muscle mass was assessed with dual-energy X-ray absorptiometry and glycemic control by oral glucose tolerance test. Statistical analyses were performed using a linear mixed model.

resultsThere was a nonsignificant increase in leg muscle mass (+0.28 kg; 95% CI, -0.01 to 0.56) and a significant increase in appendicular muscle mass (+0.36 kg; 95% CI, 0.005 to 0.71) and total lean mass (+0.92 kg; 95% CI, 0.19 to 1.65) in test vs. control. Insulin sensitivity (Matsuda index) also increased in test vs. control (+0.52; 95% CI, 0.07 to 0.97).

conclusionsUse of an enriched protein drink during combined lifestyle intervention shows beneficial effects on muscle mass and glycemic control in older adults with obesity and type 2 diabetes.

Indexed as

Life StyleMusclesAbsorptiometry, PhotonAgedAnthropometryBody CompositionDiabetes Mellitus, Type 2Dietary ProteinsDouble-Blind MethodExerciseFemaleGlucose Tolerance TestGlycemic ControlHumansInsulin ResistanceLeucineDietary ProteinsLeucineProteinsVitamin Ddiabeteselderlyinsulin sensitivitylean massoverweightproteinweight loss

Identifiers

PMID33379181
PMCPMC7823734
OpenAlexW3113951409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.